NCT/Study#
NCT04083976 /
42756493CAN2002
A Phase 2 Study Of Erdafitinib In Subjects With Advanced Solid Tumors And Selected FGFR Gene Alterations.
DISEASE GROUP:
Phase 1 Clinical Trials
current phase:
Phase II
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information:
Call 201-518-3587
